Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration

    Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

    45 Citations (Scopus)

    Abstract

    The use of systemic siRNA therapeutics for RNA interference-mediated silencing of disease genes is limited by serum instability and inadequate biodistribution. We have previously reported on the EGFP gene silencing effect of chitosan/siRNA nanoparticles in the bronchoepithelium of mice lungs following intranasal delivery and improved serum stability and reduced off-targeting effects in vitro by incorporation of locked nucleic acid (LNA). In this study, we examine the pulmonary gene silencing effect of siLNAs targeting enhanced-green-fluorescent-protein (EGFP) in lung bronchoepithelium upon intravenous delivery of naked siLNAs and upon intranasal delivery of either naked siLNA or chitosan/siLNA nanoparticles. We show that naked siLNA administered intravenously efficiently reduces the EGFP protein expression. A similar effect is obtained with intranasal delivery of chitosan nanoparticles containing siLNA whereas intranasally instilled naked siLNA did not cause a knockdown.
    Original languageEnglish
    JournalOligonucleotides
    Volume19
    Issue2
    Pages (from-to)163-8
    Number of pages5
    ISSN1545-4576
    DOIs
    Publication statusPublished - 2009

    Keywords

    • Animals
    • Bronchi
    • Chitosan
    • Drug Carriers
    • Gene Silencing
    • Green Fluorescent Proteins
    • Injections, Intravenous
    • Mice
    • Mice, Inbred C57BL
    • Mice, Transgenic
    • Nanoparticles
    • Oligonucleotides
    • RNA, Small Interfering
    • Respiratory Mucosa

    Fingerprint

    Dive into the research topics of 'Naked siLNA-mediated gene silencing of lung bronchoepithelium EGFP expression after intravenous administration'. Together they form a unique fingerprint.

    Cite this